The US Food and Drug Administration (FDA) has granted 510(k) clearance for radiotherapy devices provider Qfix for its Encompass SRS immobilisation system for use in stereotactic radiosurgery (SRS).

Encompass, which is currently used for intracranial radiotherapy treatments, is cleared to achieve sub-millimetre immobilisation to precisely treat multiple lesions with a single isocentre.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Qfix CEO Dan Coppens said: "We are delighted to receive FDA clearance. The potential clinical benefits for patients are significant."

The system uses a posterior thermoplastic and anterior open view mask that is compatible with optical tracking systems.

Encompass SRS immobilisation system when combined with SRS Fibreplast system provides high-precision, sub-millimeter accuracy and immobilisation for stereotactic radiosurgery.

See Also:

"The potential clinical benefits for patients are significant."

An optional IntegraBite can also be used to further reduce motion and provide a maximum dose to the tumour, while minimising radiation delivered to surrounding healthy tissue.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The integrated Shim system of the SRS Fibreplast system provides a 4mm range of height adjustment using discrete 0.5mm increments to optimise immobilisation.

The SRS immobilisation system is designed to optimise workflow efficiencies, increase patient throughput and improve patient outcomes.

The company is providing the Encompass SRS immobilisation system as a kVue insert for use in simulation on kVue CT and treatment on kVue couch top.

kVue couch top is a standalone device for use with non-kVue CT simulation and treatment surfaces. It is currently available in an MRI compatible standalone device for MR imaging and treatment (patents pending).